Skip to main content
Journal ArticleOPEN ACCESS

Effectiveness of Rituximab in Severe Wegener`s Granulomatosis: Report of Two Cases and Review of the Literature

  • Oristrell J
  • Bejarano G
  • Jordana R
  • et al.
The Open Respiratory Medicine Journal (2009) 3(1) 94-99
DOI: 10.2174/1874306400903010094
14Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

We hereby describe the satisfactory evolution of rituximab treatment in two patients with Wegener's granulomatosis (WG). Rituximab was indicated for refractoriness to standard treatment in one case and life-threatening myelotoxicity due to alkylating agents in the other. A brief review of previous experience with the use of rituximab in the treatment of WG is presented.

Cite

CITATION STYLE

APA

Oristrell, J., Bejarano, G., Jordana, R., Monteagudo, M., Mari, B., Casanovas, A., & Tolosa, C. (2009). Effectiveness of Rituximab in Severe Wegener`s Granulomatosis: Report of Two Cases and Review of the Literature. The Open Respiratory Medicine Journal, 3(1), 94–99. https://doi.org/10.2174/1874306400903010094

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free